Epcoritamab for diffuse large B-cell lymphoma in a dialysis-dependent patient

Leukemia & lymphoma/Leukemia and lymphoma 2026

View at publisher
Authors: Sophie Georgie Suke, Henry Miles Prince
DOI: 10.1080/10428194.2026.2617970
Cited by: 0
References: 9

Abstract

Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma with an estimated 30% of patients being refractory, or relapsing within two years of first-line treatment [1]. Treatment options fo...

Fields of Study & Subjects

Lymphoma Diagnosis and Treatment Chronic Lymphocytic Leukemia Research CNS Lymphoma Diagnosis and Treatment

Publication details

Journal / source
Leukemia & lymphoma/Leukemia and lymphoma
Volume
67
Issue
6
Pages
1400–1402
Publication date
19 January 2026
Language
EN